Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Shares Issued (2016 - 2025)

Anaptysbio's Shares Issued history spans 10 years, with the latest figure at $12.2 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 2100.36% year-over-year to $12.2 million; the TTM value through Dec 2025 reached $14.3 million, up 446.61%, while the annual FY2025 figure was $14.3 million, 120.32% up from the prior year.
  • Shares Issued reached $12.2 million in Q4 2025 per ANAB's latest filing, up from $336000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $12.2 million in Q4 2025 to a low of $160000.0 in Q3 2023.
  • Average Shares Issued over 5 years is $1.8 million, with a median of $811000.0 recorded in 2024.
  • Peak YoY movement for Shares Issued: skyrocketed 2800.6% in 2022, then tumbled 94.07% in 2023.
  • A 5-year view of Shares Issued shows it stood at $1.6 million in 2021, then skyrocketed by 114.9% to $3.4 million in 2022, then plummeted by 92.28% to $264000.0 in 2023, then skyrocketed by 110.23% to $555000.0 in 2024, then surged by 2100.36% to $12.2 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Shares Issued are $12.2 million (Q4 2025), $336000.0 (Q3 2025), and $1.4 million (Q2 2025).